The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI Medicine Software Market Research Report 2024
Synopsis
The global AI Medicine Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for AI Medicine Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Medicine Software.
Report Scope
The AI Medicine Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI Medicine Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Medicine Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enlitic
Atomwise
DeepMind
Babylon Health
Flatiron Health
Tempus Labs
Sophia Genetics
Recursion Pharmaceuticals
Synyi
Freenome
GNS Healthcare
Olive
Ada Health
Clarify Health Solutions
Sight Diagnostics
Segment by Type
Diagnosis Processes
Treatment Protocol Development
Drug Development
Personalized Medicine
Patient Monitoring and Care
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Medicine Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global AI Medicine Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for AI Medicine Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Medicine Software.
Report Scope
The AI Medicine Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI Medicine Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Medicine Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enlitic
Atomwise
DeepMind
Babylon Health
Flatiron Health
Tempus Labs
Sophia Genetics
Recursion Pharmaceuticals
Synyi
Freenome
GNS Healthcare
Olive
Ada Health
Clarify Health Solutions
Sight Diagnostics
Segment by Type
Diagnosis Processes
Treatment Protocol Development
Drug Development
Personalized Medicine
Patient Monitoring and Care
Segment by Application
Hospital
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Medicine Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Medicine Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnosis Processes
1.2.3 Treatment Protocol Development
1.2.4 Drug Development
1.2.5 Personalized Medicine
1.2.6 Patient Monitoring and Care
1.3 Market by Application
1.3.1 Global AI Medicine Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Medicine Software Market Perspective (2019-2030)
2.2 AI Medicine Software Growth Trends by Region
2.2.1 Global AI Medicine Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI Medicine Software Historic Market Size by Region (2019-2024)
2.2.3 AI Medicine Software Forecasted Market Size by Region (2025-2030)
2.3 AI Medicine Software Market Dynamics
2.3.1 AI Medicine Software Industry Trends
2.3.2 AI Medicine Software Market Drivers
2.3.3 AI Medicine Software Market Challenges
2.3.4 AI Medicine Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Medicine Software Players by Revenue
3.1.1 Global Top AI Medicine Software Players by Revenue (2019-2024)
3.1.2 Global AI Medicine Software Revenue Market Share by Players (2019-2024)
3.2 Global AI Medicine Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Medicine Software Revenue
3.4 Global AI Medicine Software Market Concentration Ratio
3.4.1 Global AI Medicine Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Medicine Software Revenue in 2023
3.5 AI Medicine Software Key Players Head office and Area Served
3.6 Key Players AI Medicine Software Product Solution and Service
3.7 Date of Enter into AI Medicine Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Medicine Software Breakdown Data by Type
4.1 Global AI Medicine Software Historic Market Size by Type (2019-2024)
4.2 Global AI Medicine Software Forecasted Market Size by Type (2025-2030)
5 AI Medicine Software Breakdown Data by Application
5.1 Global AI Medicine Software Historic Market Size by Application (2019-2024)
5.2 Global AI Medicine Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI Medicine Software Market Size (2019-2030)
6.2 North America AI Medicine Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI Medicine Software Market Size by Country (2019-2024)
6.4 North America AI Medicine Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Medicine Software Market Size (2019-2030)
7.2 Europe AI Medicine Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI Medicine Software Market Size by Country (2019-2024)
7.4 Europe AI Medicine Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Medicine Software Market Size (2019-2030)
8.2 Asia-Pacific AI Medicine Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI Medicine Software Market Size by Region (2019-2024)
8.4 Asia-Pacific AI Medicine Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Medicine Software Market Size (2019-2030)
9.2 Latin America AI Medicine Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI Medicine Software Market Size by Country (2019-2024)
9.4 Latin America AI Medicine Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Medicine Software Market Size (2019-2030)
10.2 Middle East & Africa AI Medicine Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI Medicine Software Market Size by Country (2019-2024)
10.4 Middle East & Africa AI Medicine Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Enlitic
11.1.1 Enlitic Company Detail
11.1.2 Enlitic Business Overview
11.1.3 Enlitic AI Medicine Software Introduction
11.1.4 Enlitic Revenue in AI Medicine Software Business (2019-2024)
11.1.5 Enlitic Recent Development
11.2 Atomwise
11.2.1 Atomwise Company Detail
11.2.2 Atomwise Business Overview
11.2.3 Atomwise AI Medicine Software Introduction
11.2.4 Atomwise Revenue in AI Medicine Software Business (2019-2024)
11.2.5 Atomwise Recent Development
11.3 DeepMind
11.3.1 DeepMind Company Detail
11.3.2 DeepMind Business Overview
11.3.3 DeepMind AI Medicine Software Introduction
11.3.4 DeepMind Revenue in AI Medicine Software Business (2019-2024)
11.3.5 DeepMind Recent Development
11.4 Babylon Health
11.4.1 Babylon Health Company Detail
11.4.2 Babylon Health Business Overview
11.4.3 Babylon Health AI Medicine Software Introduction
11.4.4 Babylon Health Revenue in AI Medicine Software Business (2019-2024)
11.4.5 Babylon Health Recent Development
11.5 Flatiron Health
11.5.1 Flatiron Health Company Detail
11.5.2 Flatiron Health Business Overview
11.5.3 Flatiron Health AI Medicine Software Introduction
11.5.4 Flatiron Health Revenue in AI Medicine Software Business (2019-2024)
11.5.5 Flatiron Health Recent Development
11.6 Tempus Labs
11.6.1 Tempus Labs Company Detail
11.6.2 Tempus Labs Business Overview
11.6.3 Tempus Labs AI Medicine Software Introduction
11.6.4 Tempus Labs Revenue in AI Medicine Software Business (2019-2024)
11.6.5 Tempus Labs Recent Development
11.7 Sophia Genetics
11.7.1 Sophia Genetics Company Detail
11.7.2 Sophia Genetics Business Overview
11.7.3 Sophia Genetics AI Medicine Software Introduction
11.7.4 Sophia Genetics Revenue in AI Medicine Software Business (2019-2024)
11.7.5 Sophia Genetics Recent Development
11.8 Recursion Pharmaceuticals
11.8.1 Recursion Pharmaceuticals Company Detail
11.8.2 Recursion Pharmaceuticals Business Overview
11.8.3 Recursion Pharmaceuticals AI Medicine Software Introduction
11.8.4 Recursion Pharmaceuticals Revenue in AI Medicine Software Business (2019-2024)
11.8.5 Recursion Pharmaceuticals Recent Development
11.9 Synyi
11.9.1 Synyi Company Detail
11.9.2 Synyi Business Overview
11.9.3 Synyi AI Medicine Software Introduction
11.9.4 Synyi Revenue in AI Medicine Software Business (2019-2024)
11.9.5 Synyi Recent Development
11.10 Freenome
11.10.1 Freenome Company Detail
11.10.2 Freenome Business Overview
11.10.3 Freenome AI Medicine Software Introduction
11.10.4 Freenome Revenue in AI Medicine Software Business (2019-2024)
11.10.5 Freenome Recent Development
11.11 GNS Healthcare
11.11.1 GNS Healthcare Company Detail
11.11.2 GNS Healthcare Business Overview
11.11.3 GNS Healthcare AI Medicine Software Introduction
11.11.4 GNS Healthcare Revenue in AI Medicine Software Business (2019-2024)
11.11.5 GNS Healthcare Recent Development
11.12 Olive
11.12.1 Olive Company Detail
11.12.2 Olive Business Overview
11.12.3 Olive AI Medicine Software Introduction
11.12.4 Olive Revenue in AI Medicine Software Business (2019-2024)
11.12.5 Olive Recent Development
11.13 Ada Health
11.13.1 Ada Health Company Detail
11.13.2 Ada Health Business Overview
11.13.3 Ada Health AI Medicine Software Introduction
11.13.4 Ada Health Revenue in AI Medicine Software Business (2019-2024)
11.13.5 Ada Health Recent Development
11.14 Clarify Health Solutions
11.14.1 Clarify Health Solutions Company Detail
11.14.2 Clarify Health Solutions Business Overview
11.14.3 Clarify Health Solutions AI Medicine Software Introduction
11.14.4 Clarify Health Solutions Revenue in AI Medicine Software Business (2019-2024)
11.14.5 Clarify Health Solutions Recent Development
11.15 Sight Diagnostics
11.15.1 Sight Diagnostics Company Detail
11.15.2 Sight Diagnostics Business Overview
11.15.3 Sight Diagnostics AI Medicine Software Introduction
11.15.4 Sight Diagnostics Revenue in AI Medicine Software Business (2019-2024)
11.15.5 Sight Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
